ctrl K

Watchlist Price Alert

Hillstream BioPharma Inc. (HILS)

NASDAQ: HILS · Real-Time Price · USD

0.24

0.02 (7.00%)

At close: Sep 22, 2023, 7:59 PM

Hillstream BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-9.46M	-6.88M	-3.21M	-1.81M	-1.42M
Interest Income	152.63K	n/a	n/a	n/a	n/a
Pretax Income	-9.32M	-8.47M	-2.21M	-2.42M	-1.53M
Net Income	-9.32M	-8.47M	-3.04M	-2.37M	-1.17M
Selling & General & Admin	5.9M	4.6M	1.37M	671.88K	625.81K
Research & Development	3.56M	2.28M	1.84M	847.27K	368.73K
Other Expenses	n/a	n/a	1.83M	-362.49K	-26.46K
Operating Expenses	9.46M	6.88M	3.21M	1.52M	994.54K
Interest Expense	-16.5K	1.59M	831.28K	246.53K	75.07K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.46M	6.88M	3.21M	1.52M	994.54K
Income Tax Expense	n/a	n/a	831.28K	-42.67K	-354.33K
Shares Outstanding (Basic)	1.31M	11.23M	10.3M	11.23M	11.23M
Shares Outstanding (Diluted)	1.31M	11.23M	10.3M	11.23M	11.23M
EPS (Basic)	-7.14	-0.75	-0.3	-0.21	-0.1
EPS (Diluted)	-7.14	-0.75	-0.3	-0.21	-0.1
EBITDA	-9.46M	-6.88M	-1.38M	-1.88M	-1.02M
EBIT	-9.34M	n/a	-1.38M	-2.17M	-1.45M
Depreciation & Amortization	167.9K	1.57B	1.83M	-73.29K	402.94K